ProfileGDS4718 / 243026_x_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 82% 83% 73% 82% 83% 75% 76% 83% 84% 83% 84% 82% 78% 81% 80% 80% 81% 81% 71% 71% 80% 81% 84% 82% 80% 77% 81% 77% 83% 79% 79% 77% 82% 87% 76% 79% 84% 81% 81% 71% 83% 76% 81% 73% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]8.1429582
GSM549102patient 115, normal, homogenized [OPG study]8.1504883
GSM549104patient 119, normal, homogenized [OPG study]7.1933773
GSM549108patient 138, normal, homogenized [OPG study]7.9907182
GSM549119patient 077, normal, homogenized [OPG study]8.1181883
GSM549133patient 032, cancer, homogenized [OPG study]7.4460575
GSM549139patient 042, cancer, homogenized [OPG study]7.443376
GSM549099patient 107, normal, homogenized [OPG study]8.0715183
GSM549109patient 139, normal, homogenized [OPG study]8.2684584
GSM549110patient 046, normal, homogenized [OPG study]8.1338183
GSM549114patient 063, normal, homogenized [OPG study]8.469184
GSM549122patient 082, normal, homogenized [OPG study]8.1013782
GSM549134patient 033, cancer, homogenized [OPG study]7.6963978
GSM549136patient 036, cancer, homogenized [OPG study]8.0640481
GSM549140patient 044, cancer, homogenized [OPG study]7.9064980
GSM549111patient 047, normal, homogenized [OPG study]7.9147880
GSM549113patient 057, normal, homogenized [OPG study]8.0986881
GSM549132patient 031, cancer, homogenized [OPG study]7.9268981
GSM549137patient 038, cancer, homogenized [OPG study]6.970571
GSM549142patient 047, cancer, homogenized [OPG study]6.938171
GSM549100patient 110, normal, homogenized [OPG study]7.80780
GSM549107patient 135, normal, homogenized [OPG study]7.9830181
GSM549115patient 068, normal, homogenized [OPG study]8.5269184
GSM549116patient 072, normal, homogenized [OPG study]8.096782
GSM549120patient 078, normal, homogenized [OPG study]7.8961180
GSM549131patient 030, cancer, homogenized [OPG study]7.68677
GSM549118patient 074, normal, homogenized [OPG study]8.0500281
GSM549129patient 027, cancer, homogenized [OPG study]7.6184177
GSM549123patient 088, normal, homogenized [OPG study]8.2389283
GSM549124patient 006, cancer, homogenized [OPG study]7.7234679
GSM549126patient 015, cancer, homogenized [OPG study]7.7053379
GSM549128patient 025, cancer, homogenized [OPG study]7.6529477
GSM549103patient 117, normal, homogenized [OPG study]8.0038582
GSM549117patient 073, normal, homogenized [OPG study]8.8484787
GSM549138patient 041, cancer, homogenized [OPG study]7.4469676
GSM549141patient 045, cancer, homogenized [OPG study]7.9184779
GSM549130patient 028, cancer, homogenized [OPG study]8.2839784
GSM549101patient 111, normal, homogenized [OPG study]7.8727981
GSM549105patient 128, normal, homogenized [OPG study]7.8922881
GSM549106patient 134, normal, homogenized [OPG study]7.0137471
GSM549112patient 048, normal, homogenized [OPG study]8.2892683
GSM549125patient 011, cancer, homogenized [OPG study]7.3518376
GSM549127patient 024, cancer, homogenized [OPG study]7.9617581
GSM549135patient 035, cancer, homogenized [OPG study]7.1877973